Skip to main content
Top
Published in: Neurological Sciences 12/2014

01-12-2014 | Original Article

Serum phosphate concentration and incidence of stroke: a systemic review and meta-analysis

Authors: Jing-Wei Li, Cui Xu, Ying-Bin Xiao

Published in: Neurological Sciences | Issue 12/2014

Login to get access

Abstract

Elevated serum phosphate is associated with cardiovascular and total mortality in patients with kidney diseases and healthy individuals. But whether serum phosphate is associated with stroke is controversial. We searched PubMed and Embase from January 1, 1970 to May 9, 2014 with keywords such as “serum phosphate”, “serum phosphorus”, and “stroke”. Dose–response meta-analysis was conducted. A restricted cubic spline model was used, and then we estimated pooled RR using generalized least square regression taking into account the correlation among categories of each study. Five studies with a total of 32,608 patients were included. We identified a linear relationship between serum phosphate and risk of stroke (P for non-linearity = 0.5258). The RR of phosphate (1 mg/dL) for stroke was 1.00 (95 % CI 0.97–1.05), similar results were observed in subgroup analysis. A linear relationship between serum phosphate and risk of stroke is identified. There is no association between serum level of phosphate and stroke.
Appendix
Available only for authorised users
Literature
1.
go back to reference Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA, J Am Med Assoc 305(11):1119–1127. doi:10.1001/jama.2011.308 CrossRef Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA, J Am Med Assoc 305(11):1119–1127. doi:10.​1001/​jama.​2011.​308 CrossRef
2.
go back to reference Wannamethee SG, Sattar N, Papcosta O, Lennon L, Whincup PH (2013) Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol 33(5):1070–1076PubMedCrossRef Wannamethee SG, Sattar N, Papcosta O, Lennon L, Whincup PH (2013) Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol 33(5):1070–1076PubMedCrossRef
3.
go back to reference Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C (2014) Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet 383(9913):245–254PubMedCentralPubMedCrossRef Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C (2014) Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet 383(9913):245–254PubMedCentralPubMedCrossRef
4.
go back to reference Luna JM, Moon YP, Liu KM, Spitalnik S, Paik MC, Cheung K, Sacco RL, Elkind MS (2014) High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern manhattan study. Stroke. doi:10.1161/STROKEAHA.113.002289 Luna JM, Moon YP, Liu KM, Spitalnik S, Paik MC, Cheung K, Sacco RL, Elkind MS (2014) High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern manhattan study. Stroke. doi:10.​1161/​STROKEAHA.​113.​002289
5.
go back to reference Cojocaru IM, Cojocaru M, Sapira V, Ionescu A, Barlan S, Tacu N (2013) Could pro-Bnp, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes? J Neurol Sci 333:e174–e174CrossRef Cojocaru IM, Cojocaru M, Sapira V, Ionescu A, Barlan S, Tacu N (2013) Could pro-Bnp, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes? J Neurol Sci 333:e174–e174CrossRef
6.
go back to reference Aronson D, Kapeliovich M, Hammerman H, Dragu R (2013) The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction. PLoS One 8(3):e58348PubMedCentralPubMedCrossRef Aronson D, Kapeliovich M, Hammerman H, Dragu R (2013) The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction. PLoS One 8(3):e58348PubMedCentralPubMedCrossRef
7.
go back to reference Foley RN, Collins AJ, Ishani A, Kalra PA (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the atherosclerosis risk in communities (ARIC) study. Am Heart J 156(3):556–563PubMedCrossRef Foley RN, Collins AJ, Ishani A, Kalra PA (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the atherosclerosis risk in communities (ARIC) study. Am Heart J 156(3):556–563PubMedCrossRef
9.
go back to reference Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112(17):2627–2633PubMedCrossRef Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112(17):2627–2633PubMedCrossRef
10.
go back to reference Lo CK, Mertz D, Loeb M (2014) Newcastle-Ottawa Scale: comparing reviewers′ to authors′ assessments. BMC Med Res Methodol 14:45 Lo CK, Mertz D, Loeb M (2014) Newcastle-Ottawa Scale: comparing reviewers′ to authors′ assessments. BMC Med Res Methodol 14:45
11.
go back to reference Yousaf F, Charytan C (2014) Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism. Ren Fail 36(1):131–138PubMedCrossRef Yousaf F, Charytan C (2014) Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism. Ren Fail 36(1):131–138PubMedCrossRef
12.
go back to reference Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose–response data. Stata Journal 6(1):40 Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose–response data. Stata Journal 6(1):40
Metadata
Title
Serum phosphate concentration and incidence of stroke: a systemic review and meta-analysis
Authors
Jing-Wei Li
Cui Xu
Ying-Bin Xiao
Publication date
01-12-2014
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 12/2014
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-014-1850-1

Other articles of this Issue 12/2014

Neurological Sciences 12/2014 Go to the issue